The DOI matches its Crossref record; 295 of the 295 references it cites were found in a registry or an index.
Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Open accessAbstract
Oxidative modification of LDL is known to elicit an array of pro-atherogenic responses, but it is generally underappreciated that oxidized LDL (OxLDL) exists in multiple forms, characterized by different degrees of oxidation and different mixtures of bioactive components. The variable effects of OxLDL reported in the literature can be attributed in large part to the heterogeneous nature of the preparations employed. In this review, we first describe the various subclasses and molecular composition of OxLDL, including the variety of minimally modified LDL preparations. We then describe multiple receptors that recognize various species of OxLDL and discuss the mechanisms responsible for the recognition by specific receptors. Furthermore, we discuss the contentious issues such as the nature of OxLDL in vivo and the physiological oxidizing agents, whether oxidation of LDL is a prerequisite for atherogenesis, whether OxLDL is the major source of lipids in foam cells, whether in some cases it actually induces cholesterol depletion, and finally the Janus-like nature of OxLDL in having both pro- and anti-inflammatory effects. Lastly, we extend our review to discuss the role of LDL oxidation in diseases other than atherosclerosis, including diabetes mellitus, and several autoimmune diseases, such as lupus erythematosus, anti-phospholipid syndrome, and rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–295 of 295
Lee, J. Y., Jung, G., Heo, H. J., Yun, M. R., Park, J. Y., Bae, S. S., Hong, K. W., Lee, W. S., & Kim, C. D. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2006.07.305 · Cited by 88
Endothelial scavenger receptors
ADACHI, H., & Tsujimoto, M. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.002 · Cited by 88
Lipid oxidation in atherogenesis: an overview
Jessup, W., Kritharides, L., & Stocker, R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320134 · Cited by 87
Boullier, A., Li, Y., Quehenberger, O., Palinski, W., Tabas, I. A., Witztum, J. L., & Miller, Y. I. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000210279.97308.9a · Cited by 87
Metabolism of oxidized LDL by macrophages
Jessup, W., & Kritharides, L. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00005 · Cited by 86
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
Heinecke, J. W. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060218 · Cited by 86
Intracellular Signaling of LOX-1 in Endothelial Cell Apoptosis
Li, D., & Mehta, J. L. (2009) · Circulation Research · doi:10.1161/circresaha.109.194209 · Cited by 86
Anti-inflammatory properties of lipid oxidation products
Bochkov, V. N., & Leitinger, N. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0467-2 · Cited by 85
Maor, I., & Aviram, M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39175-6 · Cited by 83
Gesquiere, L. R., Cho, W., & Subbaiah, P. V. (2002) · Biochemistry · doi:10.1021/bi015757x · Cited by 82
Self-citationCRP is a novel ligand for the oxidized LDL receptor LOX-1
Shih, H. H., Zhang, S., Cao, W., Hahn, A., Wang, J., Paulsen, J. E., & Harnish, D. C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00938.2008 · Cited by 81
Guy, E. C., Kuchibhotla, S., Silverstein, R. L., & Febbraio, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.015 · Cited by 80
Yancey, P. G., & Jerome, W. G. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32515-3 · Cited by 79
Lipid peroxidation and decomposition — Conflicting roles in plaque vulnerability and stability
Parthasarathy, S., Litvinov, D. Y., Selvarajan, K., & Garelnabi, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.03.002 · Cited by 79
Terpstra, V., Bird, D. A., & Steinberg, D. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1806 · Cited by 79
Antibodies to oxidized LDL in atherosclerosis development—clinical and animal studies
Hulthe, J. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.05.021 · Cited by 79
Oxidized LDL/β2-glycoprotein I complexes: new aspects in atherosclerosis
Matsuura, E., Kobayashi, K., Inoue, K., Lopez, L. R., & Shoenfeld, Y. (2005) · Lupus · doi:10.1191/0961203305lu2211oa · Cited by 78
New phospholipase A2 isozymes with a potential role in atherosclerosis
Murakami, M., & Kudo, I. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00003 · Cited by 77
Lu, J. X., Jiang, W., Yang, J.-H., Chang, P., Walterscheid, J. P., Chen, H., Marcelli, M., Tang, D., Lee, Y., Liao, W. S. ‐., et al. (2007) · Diabetes · doi:10.2337/db07-1287 · Cited by 74
Anderson, J. W., Gowri, M. S., Turner, J., Nichols, L., Diwadkar, V. A., Chow, C. K., & Oeltgen, P. R. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718883 · Cited by 72
Tabuchi, M., Inoue, K., Usui, H. K., Kobayashi, K., Teramoto, M., Takasugi, K., Shikata, K., Yamamura, M., Andò, K., Nishida, K., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600414-jlr200 · Cited by 71
Fibroblasts That Overexpress 15-Lipoxygenase Generate Bioactive and Minimally Modified LDL
Sigari, F., Lee, C., Witztum, J. L., & Reaven, P. D. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3639 · Cited by 70
Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity
Nègre‐Salvayre, A., Vieira, O. V., Escargueil‐Blanc, I., & Salvayre, R. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00020-7 · Cited by 70
Sphingomyelinase Activity of LDL A Link between Atherosclerosis, Ceramide, and Apoptosis?
Kinnunen, P. K. J. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00143-8 · Cited by 69
Advanced Atherosclerotic Foam Cell Formation Has Features of an Acquired Lysosomal Storage Disorder
Jerome, W. G. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.245 · Cited by 69
Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) in Atherogenesis
Kume, N. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00079-2 · Cited by 68
Tietge, U. J. F., Praticò, D., Ding, T., Funk, C. D., Hildebrand, R. B., van Berkel, T. J. C., & Eck, M. V. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400469-jlr200 · Cited by 68
Gaubatz, J. W., Gillard, B. K., Massey, J. B., Hoogeveen, R. C., Huang, M. T.-H., Lloyd, E. E., Raya, J. L., Yang, C.-Y., & Pownall, H. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600249-jlr200 · Cited by 66
Merry, P., Grootveld, M. C., Lunec, J., & Blake, D. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.1.362s · Cited by 66
Darblade, B., Caillaud, D., Poirot, M., Fouque, M., Thiers, J. C., Rami, J., Bayard, F., & Arnal, J. F. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00251-6 · Cited by 64
Jialal, I., & Chait, A. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38240-7 · Cited by 64
Lemaire‐Ewing, S., Berthier, A., Royer, M.-C., Logette, E., Corcos, L., Bouchot, A., Monier, S., Prunet, C., Raveneau, M., Rébé, C., et al. (2008) · Cell Biology and Toxicology · doi:10.1007/s10565-008-9063-0 · Cited by 63
Nakagawa, T., Akagi, M., Hoshikawa, H., Chen, M., Yasuda, T., Mukai, S., Ohsawa, K., Masaki, Τ., Nakamura, T., & Sawamura, T. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10504 · Cited by 63
Atherogenesis and the humoral immune response to modified lipoproteins
Virella, G., & Lopes-Virella, M. F. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.025 · Cited by 63
Apolipoprotein B of oxidized LDL accumulates in the lysosomes of macrophages
Mander, E. L., Dean, R. T., Stanley, K. K., & Jessup, W. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90192-9 · Cited by 63
Ashraf, M. Z., Kar, N. S., Chen, X., Choi, J., Salomon, R. G., Febbraio, M., & Podrez, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710474200 · Cited by 60
Sphingomyelinase Activity Associated with Human Plasma Low Density Lipoprotein
Holopainen, J. M., Medina, O. P., Metso, A. J., & Kinnunen, P. K. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16484 · Cited by 60
Defective catabolism of oxidized LDL by J774 murine macrophages.
Roma, P., Bernini, F., Fogliatto, R., Bertulli, S. M., Negri, S., Fumagalli, R., & Catapano, A. L. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41507-x · Cited by 59
Zhao, Z., de Beer, M. C., Cai, L., Asmis, R., de Beer, F. C., de Villiers, W. J. S., & van der Westhuyzen, D. R. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000149145.00865.d9 · Cited by 56
Minimally Modified LDL Is an Oxidized LDL Enriched with Oxidized Phosphatidylcholines
Itabe, H. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg164 · Cited by 56
Oxidized lipids: The two faces of vascular inflammation
Birukov, K. G. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0077-x · Cited by 55
The iron hypothesis—Does iron cause atherosclerosis?
Meyers, D. G. (1996) · Clinical Cardiology · doi:10.1002/clc.4960191205 · Cited by 55
Lopez, D., García-Valladares, I., Palafox‐Sánchez, C. A., Torre, I. G.-D. L., Kobayashi, K., Matsuura, E., & Lopez, L. R. (2004) · American Journal of Clinical Pathology · doi:10.1309/2aue6hd4w6tleuu5 · Cited by 55
Peters, M. J. L., van Halm, V. P., Nurmohamed, M. T., Damoiseaux, J. G. M. C., Tervaert, J. W. C., Twisk, J. W. R., Dijkmans, B. A. C., & Voskuyl, A. E. (2008) · PubMed · Cited by 55
Duenas, A. I., Aceves, M., Fernández‐Pisonero, I., Gómez, C., Orduña, A., Crespo, M. S., & García‐Rodríguez, C. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn087 · Cited by 54
Lack of a direct role for macrosialin in oxidized LDL metabolism
de Beer, M. C., Zhao, Z., Webb, N. R., van der Westhuyzen, D. R., & de Villiers, W. J. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200444-jlr200 · Cited by 54
Lopez, D., Kobayashi, K., Merrill, J. T., Matsuura, E., & Lopez, L. R. (2003) · Journal of Immunology Research · doi:10.1080/10446670310001642113 · Cited by 53
Mizutani, T., Sonoda, Y., Minegishi, T., Wakabayashi, K., & Miyamoto, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6646 · Cited by 52
Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity
Bielicki, J. K., Forte, T. M., & McCall, M. R. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42011-5 · Cited by 52
Kühn, H., Chaitidis, P., Roffeis, J., & Walther, M. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318159f177 · Cited by 51
Roma, P., Catapano, A. L., Bertulli, S. M., Varesi, L., Fumagalli, R., & Bernini, F. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91365-y · Cited by 51
Huber, J., Boechzelt, H., Karten, B., Surboeck, M., Bochkov, V. N., Binder, B. R., Sattler, W., & Leitinger, N. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012782.59850.41 · Cited by 51
Molecular characterization of a human scavenger receptor, human MARCO
Elshourbagy, N. A., Li, X., Terrett, J., VanHorn, S., Gross, M. S., Adamou, J. E., Anderson, K. M., Webb, C. L., & Lysko, P. G. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01077.x · Cited by 50
Bancells, C., Benítez, S., Villegas, S., Jorba, O. J., Ordóñez‐Llanos, J., & Sánchez‐Quesada, J. L. (2008) · Biochemistry · doi:10.1021/bi800537h · Cited by 50
Dejager, S., Mietus‐Snyder, M., & Pitas, R. E. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.3.371 · Cited by 50
Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases
Scazzocchio, B., Varí, R., D’Archivio, M., Santangelo, C., Filesi, C., Giovannini, C., & Masella, R. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800402-jlr200 · Cited by 49
Oxidized Low-Density Lipoprotein and Oxidative Stress in the Development of Glomerulosclerosis
Lee, H. S., & Song, C. Y. (2008) · American Journal of Nephrology · doi:10.1159/000151277 · Cited by 49
Higashi, Y., Peng, T., Du, J., Sukhanov, S., Li, Y., Itabe, H., Parthasarathy, S., & Delafontaine, P. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400478-jlr200 · Cited by 47
Hypochlorite-Modified LDL: Chemotactic Potential and Chemokine Induction in Human Monocytes
Woenckhaus, C., Kaufmann, A. M., Bußfeld, D., Gemsa, D., Sprenger, H., & Gröne, H. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4453 · Cited by 46
Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells
Hammad, S. M., Taha, T. A., Nareika, A., Johnson, K. R., Lopes-Virella, M. F., & Obeid, L. M. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.12.004 · Cited by 46
Kotani, K., Satoh, N., Kato, Y., Araki, R., Koyama, K., Okajima, T., Tanabe, M., Oishi, M., Yamakage, H., Yamada, K. D., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.017 · Cited by 46
Autoimmune-mediated atherothrombosis
Matsuura, E., & Lopez, L. (2008) · Lupus · doi:10.1177/0961203308093553 · Cited by 44
Lysophosphatidylcholine Promotes Cholesterol Efflux From Mouse Macrophage Foam Cells
Hara, S., Shike, T., Takasu, N., & Mizui, T. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1258 · Cited by 44
Greenspan, P., Yu, H., Mao, F., et al. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37279-5 · Cited by 43
Covalent Binding of Oxidized Cholesteryl Esters to Protein
Kawai, Y., Saito, A., Shibata, N., Kobayashi, M., Yamada, S., Osawa, T., & Uchida, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212426200 · Cited by 42
Grandl, M., Bared, S. M., Liebisch, G., et al. (2006) · Cytometry Part A · doi:10.1002/cyto.a.20232 · Cited by 41
Raghavamenon, A. C., Garelnabi, M., Babu, S. A., Aldrich, A. M., Litvinov, D. Y., & Parthasarathy, S. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2248 · Cited by 41
Platelet Interaction with Bioactive Lipids Formed by Mild Oxidation of Low-Density Lipoprotein
Siess, W. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093222 · Cited by 41
Cui, M., Laag, E. M., Sun, L., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000214980.90567.b5 · Cited by 41
Chang, C., Hsu, H., Lin, H., Chiang, W., & Lee, H. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.05.002 · Cited by 38
Expression and tissue localization of collectin placenta 1 (CL-P1, SRCL) in human tissues
Selman, L., Skjødt, K., Nielsen, O., Floridon, C., Holmskov, U., & Hansen, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.02.018 · Cited by 38
McCall, M. R., Carr, A. C., Forte, T. M., & Frei, B. B. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.1040 · Cited by 35
Boyanovsky, B. B., Karakashian, A., King‐Pospisil, K., Giltiay, N. V., & Nikolova‐Karakashian, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301536200 · Cited by 34
Singh, D. K., & Subbaiah, P. V. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600421-jlr200 · Cited by 34
Self-citationCholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPARα
Jedidi, I., Couturier, M., Thérond, P., Gardès-Albert, M., Legrand, A., Barouki, R., Bonnefont‐Rousselot, D., & Aggerbeck, Μ. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.122 · Cited by 33
Nakamura, K. D., Funakoshi, H., Tokunaga, F., & Nakamura, T. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00284-6 · Cited by 33
Kakutani, M., Ueda, M., Naruko, T., Masaki, Τ., & Sawamura, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4508 · Cited by 32
Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized
James, M. J., van Reyk, D. M., Rye, K., Dean, R. T., Cleland, L., Barter, P. J., & Jessup, W. (1998) · Lipids · doi:10.1007/s11745-998-0313-8 · Cited by 31
Wada, Y., Kuroda, T., Murasawa, A., Tanabe, N., Nakano, M., & Gejyo, F. (2005) · PubMed · Cited by 30
KONES, R. J. (2009) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944709337056 · Cited by 29
Tertov, V. V., Sobenin, I. A., & Orekhov, A. N. (1996) · Free Radical Research · doi:10.3109/10715769609149054 · Cited by 29
Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor
Podrez, E. A., Hoppe, G., O'NEIL, J. A., & Hoff, H. F. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01294-7 · Cited by 26
Shifting gears: liver SR-BI drives reverse cholesterol transport in macrophages
van der Velde, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26241 · Cited by 26
Pengo, V., Bison, E., Ruffatti, A., & Iliceto, S. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2007.12.028 · Cited by 26
Rios, F. J. O., Jancar, S., Melo, I. B., Ketelhuth, D. F. J., & Gidlund, M. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000185539 · Cited by 25
Kanayama, M., Yamaguchi, S., Shibata, T., Shibata, N., Kobayashi, M., Nagai, R., Arai, H., Takahashi, K., & Uchida, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703212200 · Cited by 23
Lopez, L. R., Buckner, T. R., HURLEY, B. L., Kobayashi, K., & Matsuura, E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.036 · Cited by 23
Hara, Y., Kusumi, Y., Mitsumata, M., Li, X., & Fujino, M. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-007-0158-x · Cited by 21
van den Eijnden, M. M. E. D., van Noort, J. T., Hollaar, L., van der Laarse, A., & Bertina, R. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.384 · Cited by 21
Balagopalakrishna, C., Bhunia, A. K., Rifkind, J. M., & Chatterjee, S. B. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006840927835 · Cited by 19
Allen, L., Capps, B. E., Miller, E. C., Clemmons, D. R., & Maile, L. A. (2008) · Endocrinology · doi:10.1210/en.2008-1090 · Cited by 18
Garrido‐Sánchez, L., Cardona, F., García‐Fuentes, E., Rojo‐Martínez, G., Gómez‐Zumaquero, J. M., Picón, M. J., Soriguer, F., & Tinahones, F. J. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01988.x · Cited by 16
Trigatti, B. L., & Rigotti, A. (2000) · PubMed · Cited by 14
Nakhjavani, M., Esteghamati, A., Asgarani, F., Khalilzadeh, O., Nikzamir, A., & Safari, R. (2008) · Translational research · doi:10.1016/j.trsl.2008.11.009 · Cited by 13
Gargiulo, S., Gamba, P., Sottero, B., Biasi, F., Chiarpotto, E., Serviddio, G., Vendemiale, G., Poli, G., & Leonarduzzi, G. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00454.x · Cited by 11
Cited by
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
Lippert, A. R., Van de Bittner, G. C., & Chang, C. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200126t · Cited by 798
LOX-1, OxLDL, and Atherosclerosis
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 769
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Navab, M., Reddy, S. T., Van Lenten, B. J., & Fogelman, A. M. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.222 · Cited by 656
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Silveira Rossi, J. L., Barbalho, S. M., Reverete de Araujo, R., Bechara, M. D., Sloan, K. P., & Sloan, L. A. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3502 · Cited by 604
Metadata
- Authors
- Levitan, I., Volkov, S., & Subbaiah, P. V.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2010-07
- Volume
- 13
- Issue
- 1
- Pages
- 39-75
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2049746695
- Cited by
- 473
- References
- 295
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.